Details
Stereochemistry | RACEMIC |
Molecular Formula | C18H26N4O3S |
Molecular Weight | 378.489 |
Optical Activity | ( + / - ) |
Defined Stereocenters | 5 / 5 |
E/Z Centers | 1 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
[H][C@@]12C[C@]3([H])C[C@@]1([H])[C@@]2([H])[C@]3([H])NCC4=CC=C(CSCCN\C(NC)=C/[N+]([O-])=O)O4
InChI
InChIKey=NIEBFIZWKXFMDD-BDFGZMOYSA-N
InChI=1S/C18H26N4O3S/c1-19-16(9-22(23)24)20-4-5-26-10-13-3-2-12(25-13)8-21-18-11-6-14-15(7-11)17(14)18/h2-3,9,11,14-15,17-21H,4-8,10H2,1H3/b16-9-/t11-,14+,15-,17+,18-/m1/s1
DescriptionSources: https://adisinsight.springer.com/drugs/800001980
Sources: https://adisinsight.springer.com/drugs/800001980
Venritidine [D 16637] is an H2-antagonist which appears to undergo phase I clinical trials in the United Kingdom and preclinical investigation in Germany as a gastric ulcer treatment.
Approval Year
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
NCI_THESAURUS |
C29702
Created by
admin on Sat Dec 16 16:19:42 GMT 2023 , Edited by admin on Sat Dec 16 16:19:42 GMT 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
93050-14-7
Created by
admin on Sat Dec 16 16:19:42 GMT 2023 , Edited by admin on Sat Dec 16 16:19:42 GMT 2023
|
PRIMARY | |||
|
C152853
Created by
admin on Sat Dec 16 16:19:42 GMT 2023 , Edited by admin on Sat Dec 16 16:19:42 GMT 2023
|
PRIMARY | |||
|
CHEMBL1742430
Created by
admin on Sat Dec 16 16:19:42 GMT 2023 , Edited by admin on Sat Dec 16 16:19:42 GMT 2023
|
PRIMARY | |||
|
SUB00035MIG
Created by
admin on Sat Dec 16 16:19:42 GMT 2023 , Edited by admin on Sat Dec 16 16:19:42 GMT 2023
|
PRIMARY | |||
|
119057995
Created by
admin on Sat Dec 16 16:19:42 GMT 2023 , Edited by admin on Sat Dec 16 16:19:42 GMT 2023
|
PRIMARY | |||
|
6508
Created by
admin on Sat Dec 16 16:19:42 GMT 2023 , Edited by admin on Sat Dec 16 16:19:42 GMT 2023
|
PRIMARY | |||
|
100000079078
Created by
admin on Sat Dec 16 16:19:42 GMT 2023 , Edited by admin on Sat Dec 16 16:19:42 GMT 2023
|
PRIMARY | |||
|
5U348610L6
Created by
admin on Sat Dec 16 16:19:42 GMT 2023 , Edited by admin on Sat Dec 16 16:19:42 GMT 2023
|
PRIMARY |
ACTIVE MOIETY
SALT/SOLVATE (PARENT)